![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 27, 19429-19433, July 2, 1999
From the The acylation stimulating protein (ASP) is a
76-amino acid peptide that has been proposed as a potent mediator of
triglyceride synthesis and, when functionally impaired, as a major
cause of hyperapobetalipoproteinemia (HyperapoB). Purification and
sequence analysis of ASP from human sera have revealed that ASP is
identical to the complement C3-derived activation peptide C3ades-Arg.
Because C3 is the precursor for C3ades-Arg and therefore ASP, a
deficiency in C3 would be predicted to result in a phenotype
characteristic of HyperapoB. To test this hypothesis in
vivo, the current study was undertaken in which
ASP(C3ades-Arg)-deficient mice were used as a model system. No
significant differences were found in the triglyceride, cholesterol, or
free fatty acid concentrations in the plasma of fasted normal and
ASP(C3ades-Arg)-deficient animals. In addition, plasma lipoprotein
analyses indicated that the very low density lipoprotein, low density
lipoprotein, and high density lipoprotein cholesterol and triglyceride
concentrations as well as the apolipoprotein B-48 and B-100 levels were
not significantly different in the plasma of ASP(C3ades-Arg)-deficient
and wild type mice. Furthermore, when challenged with an oral fat load, the ASP(C3ades-Arg)-deficient mice showed no impaired ability to clear
triglycerides and free fatty acids from their circulation when compared
with their wild-type littermates. Collectively, these results indicate
that ASP(C3ades-Arg) deficiency does not cause HyperapoB in mice and
that the physiological importance of impaired ASP(C3ades-Arg) function
as a cause of hyperapobetalipoproteinemia needs to be reevaluated.
Genetic Deficiency of Acylation Stimulating Protein
(ASP(C3ades-Arg)) Does Not Cause Hyperapobetalipoproteinemia in
Mice
§,
,
,
, and
Institute of Molecular Medicine for the
Prevention of Human Diseases, Houston Texas 77030, the
§ Department of Biochemistry and Molecular Biology,
University of Texas Houston Health Science Center,
Houston, Texas 77030, and the
Departments of Cell Biology and
Medicine, Baylor College of Medicine, Houston, Texas 77030
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E521 - E529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Paglialunga, P. Schrauwen, C. Roy, E. Moonen-Kornips, H. Lu, M. K C Hesselink, Y. Deshaies, D. Richard, and K. Cianflone Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice J. Endocrinol., August 1, 2007; 194(2): 293 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Persson, J. Boren, A.-K. L. Robertson, V. Wallenius, G. K. Hansson, and M. Pekna Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E-/- Low-Density Lipoprotein Receptor-/- Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 1062 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xia, K. L. Stanhope, E. Digitale, O.-M. Simion, L. Chen, P. Havel, and K. Cianflone Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice J. Biol. Chem., February 6, 2004; 279(6): 4051 - 4057. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xia, A. D. Sniderman, and K. Cianflone Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice J. Biol. Chem., November 22, 2002; 277(48): 45874 - 45879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buono, C. E. Come, J. L. Witztum, G. F. Maguire, P. W. Connelly, M. Carroll, and A. H. Lichtman Influence of C3 Deficiency on Atherosclerosis Circulation, June 25, 2002; 105(25): 3025 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis Complement activation in factor D-deficient mice PNAS, November 20, 2001; (2001) 261428398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ylitalo, P. Pajukanta, S. Meri, R. M. Cantor, N. Mero-Matikainen, J. Vakkilainen, I. Nuotio, and M.-R. Taskinen Serum C3 but Not Plasma Acylation-Stimulating Protein Is Elevated in Finnish Patients With Familial Combined Hyperlipidemia Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 838 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murray, P. J. Havel, A. D. Sniderman, and K. Cianflone Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein Endocrinology, March 1, 2000; 141(3): 1041 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice J. Biol. Chem., December 17, 1999; 274(51): 36219 - 36225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis Complement activation in factor D-deficient mice PNAS, December 4, 2001; 98(25): 14577 - 14582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |